LiquiLume Diagnostics

San Jose, United States Founded: 2010 • Age: 16 yrs
An optofluidic-based platform for immunodiagnostic solutions.
Annual revenue $5.8M Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About LiquiLume Diagnostics

LiquiLume Diagnostics is a company based in San Jose (United States) founded in 2010. It operates as a B2B. LiquiLume Diagnostics operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.

  • Headquarter San Jose, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $5.8 M (USD)
    10.32
    as on Mar 31, 2023
  • Net Profit
    $661.79 K (USD)
    -5.82
    as on Mar 31, 2023
  • EBITDA
    $5.02 M (USD)
    9.54
    as on Mar 31, 2023
  • Latest Funding Round
    $272.11 K (USD), Grant

    Jun 01, 2012

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of LiquiLume Diagnostics

Investments & Acquisitions by LiquiLume Diagnostics

Investments
Premium access

Investment portfolio details for LiquiLume Diagnostics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - LiquiLume Diagnostics

Premium access

Detailed financials for LiquiLume Diagnostics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Liquilume Diagnostics Comparisons

LiquiLume Diagnostics Primary company
Description
An optofluidic-based platform for immunodiagnostic solutions...
Location
San Jose, United States
Founded Year
2010
Annual Revenue
$5.8 M (USD)
Net Profit
$661.79 K (USD)
EBITDA
$5.02 M (USD)
Employees
Not available
Premium access

Peer comparison for LiquiLume Diagnostics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of LiquiLume Diagnostics

LiquiLume Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Digital sequencing technology for cancer detection is developed.
Locked Locked Locked
Genomics-based diagnostic tests for cancer are provided.
Locked Locked Locked
Molecular cancer diagnostic products are developed using patented AMP technology.
Locked Locked Locked
Developer of cell-free DNA testing for oncology, women’s health, and organ health
Locked Locked Locked
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
Locked Locked Locked
Health risks are identified through online genetic and diagnostic testing.
Premium access

Detailed competitors of LiquiLume Diagnostics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Liquilume Diagnostics

Premium access

Complete news archive for LiquiLume Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LiquiLume Diagnostics

LiquiLume Diagnostics was founded in 2010 and raised its 1st funding round 2 years after it was founded.

LiquiLume Diagnostics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Annual revenue of LiquiLume Diagnostics is $5.8M as on Mar 31, 2023.

LiquiLume Diagnostics, founded in 2010 in San Jose, United States, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and immunodiagnostics. An optofluidic-based platform for immunodiagnostic solutions. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

LiquiLume Diagnostics's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available